Aurinia Pharmaceuticals (AUPH) Deferred Taxes (2026)

Aurinia Pharmaceuticals (AUPH) posted Deferred Taxes of $9.3 million for Q1 2026.

Aurinia Pharmaceuticals (AUPH) Deferred Taxes (2026) Analysis & Trends

Aurinia Pharmaceuticals' Deferred Taxes history runs 1 years deep, the most recent figure standing at $9.3 million for Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -188,883.60
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -65.30 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 96.00 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Aurinia Pharmaceuticals 2.02 Bn 1.64 Bn 71.20 Mn 9.28 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 9.28 Mn